Naproxen Sodium
NDC Package 42494-402-01

11-digit billing NDC: 42494040201

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Naproxen Sodium is carefully consider the potential benefits and risks of NAPROXEN, EC-NAPROXEN, ANAPROX, ANAPROX DS or NAPROXEN Suspension and other treatment options before deciding to use NAPROXEN, EC-NAPROXEN, NAPROXEN SODIUM or NAPROXEN SODIUM DS. Marketed by Cameron Pharmaceuticals, Llc, this product is identified by NDC 42494-402 and is authorized under FDA application NDA018164.

Identification & Billing

NDC Package Code
42494-402-01
Package Description
100 TABLET in 1 BOTTLE, PLASTIC
Product Code
11-Digit Billing Format
42494040201

Clinical Specifications

Proprietary Name
Naproxen Sodium
Dosage Form
-
Usage Information
Carefully consider the potential benefits and risks of NAPROXEN, EC-NAPROXEN, ANAPROX, ANAPROX DS or NAPROXEN Suspension and other treatment options before deciding to use NAPROXEN, EC-NAPROXEN, NAPROXEN SODIUM or NAPROXEN SODIUM DS. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS: Gastrointestinal Bleeding, Ulceration, and Perforation).Naproxen as NAPROXEN, EC-NAPROXEN, NAPROXEN SODIUM or NAPROXEN SODIUM DS is indicated:For the relief of the signs and symptoms of rheumatoid arthritisFor the relief of the signs and symptoms of osteoarthritisFor the relief of the signs and symptoms of ankylosing spondylitisFor the relief of the signs and symptoms of juvenile arthritisNaproxen as NAPROXEN Suspension is recommended for juvenile rheumatoid arthritis in order to obtain the maximum dosage flexibility based on the patient’s weight.Naproxen as NAPROXEN, NAPROXEN SODIUM and NAPROXEN SODIUM DS is also indicated:For relief of the signs and symptoms of tendonitisFor relief of the signs and symptoms of bursitisFor relief of the signs and symptoms of acute goutFor the management of painFor the management of primary dysmenorrheaEC-NAPROXEN is not recommended for initial treatment of acute pain because the absorption of naproxen is delayed compared to absorption from other naproxen-containing products (see CLINICAL PHARMACOLOGY, DOSAGE AND ADMINISTRATION).

Regulatory & Marketing

Labeler Name
Cameron Pharmaceuticals, Llc
FDA Application #
NDA018164
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
07-10-2016
End Marketing Date
04-09-2026
Listing Expiration
04-09-2026
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 42494-402-01 identifies a specific commercial package of 100 tablet in 1 bottle, plastic of Naproxen Sodium, labeled by Cameron Pharmaceuticals, Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Cameron Pharmaceuticals, Llc on July 10, 2016. The current certification is valid through April 09, 2026.

How is this Cameron Pharmaceuticals, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 42494040201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
42494-402-01
11-Digit CMS (5-4-2)
42494-0402-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.